Early research (Phase 1)Study completedNCT02202447What this trial is testingPhase 1 of EC1169 In Patients With Recurrent MCRPCWho this might be right forProstate Cancer Endocyte 40
Not applicableUnknownNCT06241391What this trial is testingGa-68 Prostate Specific Membrane Antigen PET/CT in GliomasWho this might be right forGliomaAstrocytomaAnaplastic Astrocytoma+2 more All India Institute of Medical Sciences, Bhubaneswar 35
Early research (Phase 1)Looking for participantsNCT05354375What this trial is testingClinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate CancerWho this might be right forImmunotherapy The Affiliated Hospital of Xuzhou Medical University 20
Not applicableUnknownNCT03327675What this trial is testingHigh Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate CancerWho this might be right forProstate Cancer Universitaire Ziekenhuizen KU Leuven 188
Large-scale testing (Phase 3)Active Not RecruitingNCT04720157What this trial is testingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Who this might be right forProstatic Neoplasms Novartis Pharmaceuticals 1,140
Very early researchActive Not RecruitingNCT05683964What this trial is testingAndrogen Receptor Signaling and Prostate-Specific Membrane Antigen ExpressionWho this might be right forProstate AdenocarcinomaProstate CancerMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) Beth Israel Deaconess Medical Center 9
Not applicableTemporarily Not AvailableNCT06033001What this trial is testingExpanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Who this might be right forCastration-Resistant Prostatic Cancer Lantheus Medical Imaging
Early research (Phase 1)Study completedNCT01261754What this trial is testing99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy VolunteersWho this might be right forProstate Cancer Molecular Insight Pharmaceuticals, Inc. 16
Not applicableLooking for participantsNCT06335914What this trial is testingDual PSMA and FDG PET Imaging for Patients With Advanced Prostate CancerWho this might be right forAdvanced Prostate Cancer University Health Network, Toronto 30
Large-scale testing (Phase 3)Looking for participantsNCT05939414What this trial is testingAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.Who this might be right forOligometastatic Prostate Cancer (OMPC) Novartis Pharmaceuticals 450
Early research (Phase 1)Looking for participantsNCT06217822What this trial is testingFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forAdvanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression Bayer 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT05219500What this trial is testingTargeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).Who this might be right forMetastatic Castration Resistant Prostate Cancer Fusion Pharmaceuticals Inc. 115
Not applicableLooking for participantsNCT06690970What this trial is testingProstate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease PatientsWho this might be right forPSMA-related DiseaseProstate CancerPositron Emission Tomography+3 more Tianjin Medical University 500
Not applicableUnknownNCT04521894What this trial is testingThe Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate CancerWho this might be right forProstatic Neoplasms First Affiliated Hospital Xi'an Jiaotong University 500
Early research (Phase 1)Study completedNCT00705835What this trial is testingVaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant AlhydrogelWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)UnknownNCT05836623What this trial is testingA Phase I Study to Assess PSMA+ and PSMA- Tumour LesionsWho this might be right forAdvanced and/or Metastatic Solid Tumours Crescendo Biologics Ltd. 5
Not applicableStudy completedNCT05109884What this trial is testingComparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder CancerWho this might be right forProstate Cancer Medical University of Vienna 10
Early research (Phase 1)Study completedNCT00916123What this trial is testingDocetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate CancerWho this might be right forProstate Cancer Weill Medical College of Cornell University 15
Early research (Phase 1)Study completedNCT03542773What this trial is testingTargeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PETWho this might be right forSchwannomasMalignant Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Looking for participantsNCT06865768What this trial is testingAn Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion TechniqueWho this might be right forProstate Carcinoma Emory University 90